Analytical Data
-
基因名
atpG2
- Application
-
别名
(ATP synthase F1 sector gamma subunit 2)(F-ATPase gamma subunit 2)
-
种属
Photobacterium profundum
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6LKZ7
-
表达区间
1-291aa
-
分子量
40.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The ATPG2 protein, a member of the ATP-binding cassette (ABC) transporter family, plays a crucial role in various cellular processes, including energy metabolism and protein transport. Research on ATPG2 is driven by its potential implications in understanding complex diseases, particularly those associated with mitochondrial dysfunction and energy imbalance. Mitochondria serve as the powerhouse of cells, and the proper functioning of ATP transporters is essential for maintaining cellular energy homeostasis. Studies have indicated that mutations or dysregulation of ATPG2 can lead to metabolic disorders and contribute to the pathology of conditions such as neurodegenerative diseases, cancer, and metabolic syndromes. Recombinant ATPG2 protein has emerged as a valuable tool for elucidating its functional mechanism and interactions within cellular pathways. By utilizing advanced techniques such as site-directed mutagenesis and structural biology methods, researchers aim to unravel the detailed molecular architecture of ATPG2, which could pave the way for therapeutic strategies targeting ATPG2-related diseases. As our understanding of ATPG2 deepens, it may also facilitate the development of novel drugs that enhance its function or correct its deficiencies, offering new avenues for treatment in conditions associated with its impairment.
